A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

June 30, 2016

Conditions
Immune ThrombocytopeniaPregnancy
Interventions
DRUG

rhTPO

Trial Locations (1)

Unknown

Qilu Hospital, Shandong University, Jinan

All Listed Sponsors
collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Institute of Hematology & Blood Diseases Hospital, China

OTHER

collaborator

Southern Medical University, China

OTHER

lead

Shandong University

OTHER

NCT02391272 - A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy | Biotech Hunter | Biotech Hunter